JHS Svendgaard Laboratories Ltd (JHS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 150728,
    "name": "JHS Sven.Lab.",
    "stock_name": "JHS Sven.Lab.",
    "full_name": "JHS Svendgaard Laboratories Ltd",
    "name_url": "stocks-analysis/jhs-svenlab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "11.29",
    "chg": 1.03,
    "chgp": "10.04%",
    "dir": 1,
    "prev_price": "10.26",
    "mcapval": "94.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532771,
    "symbol": "JHS",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE544H01014",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.95 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/jhs-svenlab-150728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is JHS Sven.Lab. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-jhs-svenlab-fallingrising-3732044",
        "imagepath": "",
        "date": "2025-11-27 00:24:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>JHS Svendgaard Laboratories Ltd’s stock price rose by ₹0.87, or 8.25%, as of 08:21 PM on 26 November, signalling a short-term recovery after a period of sustained declines. This gain outpaced the sector’s performance by 7.56%, indicating a relative strength in the stock compared to its peers. The stock has been on a positive trajectory for two consecutive days, accumulating a 10.98% return during this brief rally.</p>\n<p>However, this recent uptick contrasts sharply with the stock’s broader performance metrics. Over the past month, the stock has declined by 16.15%, while the Sensex benchmark index has gained 1.66%. Year-to-date, JHS Svendgaard Laboratories has fallen 47.30%, whereas the Sensex has advanced 9.56%. The one-year and three..."
      },
      {
        "title": "JHS Svendgaard Q2 FY26: Persistent Losses Continue Despite Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/jhs-svendgaard-q2-fy26-persistent-losses-continue-despite-revenue-growth-3711904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JHSSvendgaardLa_quaterlyResult_3711904.png",
        "date": "2025-11-18 09:33:43",
        "description": "JHS Svendgaard Laboratories Ltd., the Himachal Pradesh-based oral care products manufacturer, reported a quarterly loss of ₹0.20 crores in Q2 FY26, marking a sharp reversal from the ₹1.06 crores profit recorded in the previous quarter. Despite achieving revenue growth of 13.21% year-on-year to ₹22.28 crores, the company's inability to convert top-line expansion into profitability continues to plague its financial performance. With a market capitalisation of just ₹102 crores and the stock trading at ₹11.80—down 46.85% over the past year—investor sentiment remains deeply pessimistic towards this micro-cap FMCG player."
      },
      {
        "title": "How has been the historical performance of JHS Sven.Lab.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-jhs-svenlab-3702868",
        "imagepath": "",
        "date": "2025-11-14 23:36:21",
        "description": "Answer:\nThe historical performance of JHS Sven.Lab. shows a fluctuating trend in net sales and profitability over the years, with significant losses in recent periods.\n\nBreakdown:\nJHS Sven.Lab. reported net sales of 92.00 Cr in March 2025, an increase from 70.80 Cr in March 2024, but a decline from 96.21 Cr in March 2023. The total operating income mirrored this trend, reaching 92.00 Cr in March 2025, while total expenditure rose to 96.01 Cr, leading to an operating profit (PBDIT) of -1.13 Cr for the same period. This marked a deterioration from the previous year's operating profit of 3.38 Cr. The company faced a profit before tax of -12.51 Cr in March 2025, worsening from -3.43 Cr in March 2024, and a profit after tax of -19.74 Cr, compared to -4.06 Cr in the prior year. The earnings per share also reflected this decline, showing -2.31 in March 2025. On the balance sheet, total liabilities increased to 197..."
      },
      {
        "title": "How has been the historical performance of JHS Sven.Lab.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-jhs-svenlab-3698866",
        "imagepath": "",
        "date": "2025-11-13 23:14:58",
        "description": "Answer:\nThe historical performance of JHS Sven.Lab. shows a fluctuating trend in net sales and profitability over the years, with significant losses reported in recent periods.\n\nBreakdown:\nJHS Sven.Lab. reported net sales of 92.00 Cr for the year ending March 2025, a notable increase from 70.80 Cr in March 2024, but a decline from 96.21 Cr in March 2023. The total operating income followed a similar pattern, reaching 92.00 Cr in March 2025, up from 70.80 Cr in the previous year. However, the company faced rising raw material costs, which increased to 57.46 Cr in March 2025 from 40.83 Cr in March 2024. Operating profit (PBDIT) was negative at -1.13 Cr in March 2025, down from a positive 3.38 Cr in March 2024, indicating ongoing challenges in managing expenses. The profit before tax also worsened to -12.51 Cr in March 2025 from -3.43 Cr in March 2024, while the profit after tax showed a significant loss of -1..."
      },
      {
        "title": "When is the next results date for JHS Sven.Lab.?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-jhs-svenlab-3693874",
        "imagepath": "",
        "date": "2025-11-12 23:16:23",
        "description": "JHS Sven.Lab. will declare its results on 14 November 2025...."
      },
      {
        "title": "When is the next results date for JHS Sven.Lab.?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-jhs-svenlab-3691051",
        "imagepath": "",
        "date": "2025-11-11 23:17:35",
        "description": "JHS Sven.Lab. will declare its results on 14 November 2025...."
      },
      {
        "title": "Why is JHS Sven.Lab. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-jhs-svenlab-fallingrising-3690696",
        "imagepath": "",
        "date": "2025-11-11 21:31:25",
        "description": "As of 11-Nov, JHS Svendgaard Laboratories Ltd is experiencing a decline in its stock price, currently at 12.05, which reflects a decrease of 0.26 or 2.11%. The stock has underperformed its sector today by 2.26% and has been on a downward trend for the last two days, accumulating a total loss of 3.83%. Over the past week, the stock has seen a decline of 1.55%, while its performance over the year-to-date shows a significant drop of 44.39%. Despite being higher than the 50-day moving average, it remains lower than the 5-day, 20-day, 100-day, and 200-day moving averages. Notably, there has been a rise in investor participation, with delivery volume increasing by 8.93% against the 5-day average, indicating some interest despite the overall negative performance.\n\nIn the broader market context, the stock's recent performance contrasts sharply with the Sensex, which has gained 0.49% over the past week and 7.34% yea..."
      }
    ],
    "total": 166,
    "sid": "150728",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/jhs-svendgaard-laboratories-150728"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment",
      "datetime": "01-Feb-2026",
      "details": "The Board of Directors at their meeting held on 01st February 2026 approved the allotment of 1801801 equity shares at an issue price 27.75 through conversion of warrants",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "12-Jan-2026",
      "details": "Compliance Certificate under Regulation 74(5) of DP Regulations 2015 for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Dec-2025",
      "details": "Intimation of Closure of Trading Window for the Quarter ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "JHS Svendgaard Laboratories Ltd has declared <strong>8%</strong> dividend, ex-date: 26 Dec 11",
          "dt": "2011-12-26",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is JHS Sven.Lab. falling/rising?

2025-11-27 00:24:57

Recent Price Movement and Market Context JHS Svendgaard Laboratories Ltd’s stock price rose by ₹0.87, or 8.25%, as of 08:21 PM on 26 November, signalling a short-term recovery after a period of sustained declines. This gain outpaced the sector’s performance by 7.56%, indicating a relative strength in the stock compared to its peers. The stock has been on a positive trajectory for two consecutive days, accumulating a 10.98% return during this brief rally. However, this recent uptick contrasts sharply with the stock’s broader performance metrics. Over the past month, the stock has declined by 16.15%, while the Sensex benchmark index has gained 1.66%. Year-to-date, JHS Svendgaard Laboratories has fallen 47.30%, whereas the Sensex has advanced 9.56%. The one-year and three...

JHS Svendgaard Q2 FY26: Persistent Losses Continue Despite Revenue Growth

2025-11-18 09:33:43

JHS Svendgaard Laboratories Ltd., the Himachal Pradesh-based oral care products manufacturer, reported a quarterly loss of ₹0.20 crores in Q2 FY26, marking a sharp reversal from the ₹1.06 crores profit recorded in the previous quarter. Despite achieving revenue growth of 13.21% year-on-year to ₹22.28 crores, the company's inability to convert top-line expansion into profitability continues to plague its financial performance. With a market capitalisation of just ₹102 crores and the stock trading at ₹11.80—down 46.85% over the past year—investor sentiment remains deeply pessimistic towards this micro-cap FMCG player.

How has been the historical performance of JHS Sven.Lab.?

2025-11-14 23:36:21

Answer: The historical performance of JHS Sven.Lab. shows a fluctuating trend in net sales and profitability over the years, with significant losses in recent periods. Breakdown: JHS Sven.Lab. reported net sales of 92.00 Cr in March 2025, an increase from 70.80 Cr in March 2024, but a decline from 96.21 Cr in March 2023. The total operating income mirrored this trend, reaching 92.00 Cr in March 2025, while total expenditure rose to 96.01 Cr, leading to an operating profit (PBDIT) of -1.13 Cr for the same period. This marked a deterioration from the previous year's operating profit of 3.38 Cr. The company faced a profit before tax of -12.51 Cr in March 2025, worsening from -3.43 Cr in March 2024, and a profit after tax of -19.74 Cr, compared to -4.06 Cr in the prior year. The earnings per share also reflected this decline, showing -2.31 in March 2025. On the balance sheet, total liabilities increased to 197...

How has been the historical performance of JHS Sven.Lab.?

2025-11-13 23:14:58

Answer: The historical performance of JHS Sven.Lab. shows a fluctuating trend in net sales and profitability over the years, with significant losses reported in recent periods. Breakdown: JHS Sven.Lab. reported net sales of 92.00 Cr for the year ending March 2025, a notable increase from 70.80 Cr in March 2024, but a decline from 96.21 Cr in March 2023. The total operating income followed a similar pattern, reaching 92.00 Cr in March 2025, up from 70.80 Cr in the previous year. However, the company faced rising raw material costs, which increased to 57.46 Cr in March 2025 from 40.83 Cr in March 2024. Operating profit (PBDIT) was negative at -1.13 Cr in March 2025, down from a positive 3.38 Cr in March 2024, indicating ongoing challenges in managing expenses. The profit before tax also worsened to -12.51 Cr in March 2025 from -3.43 Cr in March 2024, while the profit after tax showed a significant loss of -1...

When is the next results date for JHS Sven.Lab.?

2025-11-12 23:16:23

JHS Sven.Lab. will declare its results on 14 November 2025....

When is the next results date for JHS Sven.Lab.?

2025-11-11 23:17:35

JHS Sven.Lab. will declare its results on 14 November 2025....

Why is JHS Sven.Lab. falling/rising?

2025-11-11 21:31:25

As of 11-Nov, JHS Svendgaard Laboratories Ltd is experiencing a decline in its stock price, currently at 12.05, which reflects a decrease of 0.26 or 2.11%. The stock has underperformed its sector today by 2.26% and has been on a downward trend for the last two days, accumulating a total loss of 3.83%. Over the past week, the stock has seen a decline of 1.55%, while its performance over the year-to-date shows a significant drop of 44.39%. Despite being higher than the 50-day moving average, it remains lower than the 5-day, 20-day, 100-day, and 200-day moving averages. Notably, there has been a rise in investor participation, with delivery volume increasing by 8.93% against the 5-day average, indicating some interest despite the overall negative performance. In the broader market context, the stock's recent performance contrasts sharply with the Sensex, which has gained 0.49% over the past week and 7.34% yea...

View All News